HK1262425A1 - Spiroheptane salicylamides and related compounds as inhibitors of rock - Google Patents

Spiroheptane salicylamides and related compounds as inhibitors of rock Download PDF

Info

Publication number
HK1262425A1
HK1262425A1 HK19122246.2A HK19122246A HK1262425A1 HK 1262425 A1 HK1262425 A1 HK 1262425A1 HK 19122246 A HK19122246 A HK 19122246A HK 1262425 A1 HK1262425 A1 HK 1262425A1
Authority
HK
Hong Kong
Prior art keywords
rock
inhibitors
related compounds
salicylamides
spiroheptane
Prior art date
Application number
HK19122246.2A
Other languages
Chinese (zh)
Inventor
M. Smith Ii Leon
Ladziata Vladimir
Delucca Indawati
J. P. PINTO Donald
J. Orwat Michael
K. Dilger Andrew
Balashanmuga Pabbisetty Kumar
Yang Wu
A. SHAW Scott
W. Glunz Peter
Panda Manoranjan
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HK1262425A1 publication Critical patent/HK1262425A1/en

Links

HK19122246.2A 2016-01-13 2017-01-13 Spiroheptane salicylamides and related compounds as inhibitors of rock HK1262425A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/278,122 2016-01-13

Publications (1)

Publication Number Publication Date
HK1262425A1 true HK1262425A1 (en) 2020-01-17

Family

ID=

Similar Documents

Publication Publication Date Title
IL260448B (en) Spiroheptane salicylamides and related compounds as inhibitors of rock
IL263163A (en) Substituted pyridines as inhibitors of dnmt1
IL261167A (en) Heteroaryl inhibitors of pad4
ZA201700304B (en) Spirocycloheptanes as inhibitors of rock
EP3102576B8 (en) Dihydropyrrolopyridine inhibitors of ror-gamma
EP3322711A4 (en) Hpk1 inhibitors and methods of using same
EP3558998A4 (en) Ectonucleotidase inhibitors and methods of use thereof
IL259796A (en) Aza-benzimidazole inhibitors of pad4
PL3555070T3 (en) Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof
EP3250229A4 (en) Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy
IL257061A (en) Inhibitors of ezh2
EP3193876A4 (en) Crystal forms of glutaminase inhibitors
EP3405477C0 (en) Inhibitors of transglutaminases
EP3177327A4 (en) Inhibitors of myh7b and uses thereof
EP3256450A4 (en) Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
PT3458448T (en) Methods of using fasn inhibitors
GB201708457D0 (en) Inhibitors of metallo-beta-lactamases
IL247678A0 (en) Amido-substituted azole compounds as inhibitors of tnks1 and/or tnks2
EP3284746A4 (en) Preparation and use of kinase inhibitor
AU2016205137B2 (en) Furoquinolinediones as inhibitors of TDP2
EP3102567A4 (en) Inhibitors of paxillin function and related compositions and methods
GB201708451D0 (en) Inhibitors of metallo-beta-lactamases
EP3223613A4 (en) 4-fluoro-thio-containing inhibitors of app2, compositions thereof and method of use
HK40007210A (en) Substituted pyridines as inhibitors of dnmt1
AU2017904351A0 (en) Inhibitors of necroptosis